Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Sensing Array Speeds Diagnosis of Sepsis

By LabMedica International staff writers
Posted on 26 Sep 2013
The odor released by some of the most pathogenic microbes has become the basis for a faster and simpler way to diagnose blood infections and identify the specific microorganism.

This latest test produces results in 24 hours, compared to as much as 72 hours required with the test hospitals now use, and is suitable for use in developing countries and other areas that lack expensive equipment in clinical laboratories. More...


Scientists at the University of Illinois (Champaign, IL, USA) developed an inexpensive disposable liquid culture bottle that detects and identifies opportunistic human pathogenic microorganisms at clinically relevant concentrations in liquid media during cell culture. The device combines amplification of bacteria with detection and identification in a single sealed bottle. This single step device is composed of a nonsterile chemical sensing array that is strategically interfaced with a culture bottle, without compromising the sterility of the device.

The device consists of a plastic bottle, small enough to fit in the palm of a hand, filled with nutrient solution for bacteria to grow. Attached to the inside is a chemical sensing array (CSA), with 36 pigment dots. The dots change color in response to signature odor chemicals released by bacteria. A blood sample from a patient is injected into the bottle, which goes onto a simple shaker device to agitate the nutrient solution and encourage bacterial growth. Any bacteria present in the blood sample will grow and release a signature odor that changes the colors of pigment dots on the sensor. The test is complete within a day, and the results can be read in a pattern of color changes unique to each strain of bacteria.

The device can identify eight of the most common disease-causing bacteria with almost 99% accuracy under clinically relevant conditions. Other microorganisms can cause sepsis, and the scientists are working to expand the test's capabilities as the device could make an impact now in reducing the toll of sepsis. The results from nine microorganisms, including two strains of Escherichia coli and two strains of Enterococcus faecalis, illustrated the high reproducibility and identification ability of this technology.

James Carey, PhD, from the National University of Kaohsiung (Taiwan) and senior author said, “Our CSA blood culture bottle can be used almost anywhere in the world for a very low cost and minimal training. All you need is someone to draw a blood sample, an ordinary shaker, incubator, a desktop scanner, and a computer.” The study was presented at the 246th National Meeting & Exposition of the American Chemical Society held September 8–12, 2013 in Indianapolis (IN, USA).

Related Links:

University of Illinois
National University of Kaohsiung



Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Homocysteine Quality Control
Liquichek Homocysteine Control
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.